Research Topics
Genomes and GenesSpecies | J M SchildkrautSummaryAffiliation: Duke University Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer riskJoellen M Schildkraut
Department of Community and Family Medicine, Duke Comprehensive Cancer Center, Duke University Medical Center, Durham, NC 27710, USA
J Natl Cancer Inst 94:32-8. 2002..In this study, we investigate the relationship between the progestin and estrogen potency in combination OCs and the risk of developing ovarian cancer...
Analgesic drug use and risk of ovarian cancerJoellen M Schildkraut
Duke Comprehensive Cancer Center, Cancer Prevention, Detection and Control Research Program, Duke University Medical Center, Durham, North Carolina 27710, USA
Epidemiology 17:104-7. 2006..Previous epidemiologic research suggests that analgesic use may reduce the risk of ovarian cancer, although results are not consistent...
Primary peritoneal and ovarian cancers: an epidemiological comparative analysisDelores J Grant
Department of Biology, North Carolina Central University, JLC Biomedical Biotechnology Research Institute, Durham, NC, USA
Cancer Causes Control 21:991-8. 2010..A larger study to determine risk factors for invasive serous PPC is warranted...
Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST)Cathrine Hoyo
Department of Community and Family Medicine and Program of Cancer Detection, Prevention and Control, Duke University, PO Box 104006, Durham, NC 27710, USA
BMC Public Health 11:46. 2011..The primary objective is to estimate the proportion of women taking folic acid (FA) doses exceeding the TUL before and during pregnancy, and to identify correlates of high FA use...
Activating mutation in MET oncogene in familial colorectal cancerDeborah W Neklason
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
BMC Cancer 11:424. 2011..Familial colorectal cancer has been linked to chromosome 7q31 by multiple affected relative pair studies. The MET proto-oncogene which resides in this chromosomal region is considered a candidate for genetic susceptibility...
Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancerKristin L White
Mayo Clinic College of Medicine, Rochester, MN, USA
BMC Cancer 9:170. 2009..Inhibitors of kappaB (IkappaB) prevent NF-kappaB activation by sequestering NF-kappaB proteins in the cytoplasm until IkappaB proteins are phosphorylated and degraded...
Association between DNA damage response and repair genes and risk of invasive serous ovarian cancerJoellen M Schildkraut
Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, United States of America
PLoS ONE 5:e10061. 2010....
Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancerJoellen M Schildkraut
Department of Community and Family Medicine, Duke University Medical Center, Box 2949, Durham, NC 27710, USA
Cancer Epidemiol Biomarkers Prev 16:473-80. 2007..Two trinucleotide repeat polymorphisms have been described in exon 1 of the androgen receptor (AR) gene that may affect its function. Previous studies of ovarian cancer and AR repeat polymorphisms have been inconsistent...
Cyclin E overexpression in epithelial ovarian cancer characterizes an etiologic subgroupJoellen M Schildkraut
Department of Community and Family Medicine, Duke University Medical Center, Box 2949, Durham, NC 27710, USA
Cancer Epidemiol Biomarkers Prev 17:585-93. 2008..The objective of this study was to determine whether cyclin E overexpression defines an etiologically distinct subgroup of ovarian cancer...
IGF1 (CA)19 repeat and IGFBP3 -202 A/C genotypes and the risk of prostate cancer in Black and White menJoellen M Schildkraut
Program of Cancer Prevention, Detection and Control Research, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA
Cancer Epidemiol Biomarkers Prev 14:403-8. 2005..Further research is needed to confirm these findings...
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancerJoellen M Schildkraut
Comprehensive Cancer Center, Department of Community and Family Medicine, Duke University Medical Center, and Department of Statistical Science, Duke University, Durham, North Carolina, USA
Cancer Res 69:2349-57. 2009..This large study provides statistical evidence for a small increase in risk of ovarian cancer associated with common variants in the TP53 region...
Environmental contaminants and body fat distributionJ M Schildkraut
Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
Cancer Epidemiol Biomarkers Prev 8:179-83. 1999..In addition, BMI may affect circulating levels of contaminants and should also be considered a potentially important modifying factor for exposure to lipophilic substances...
Prognostic factors in early-onset epithelial ovarian cancer: a population-based studyJ M Schildkraut
Department of Cancer Prevention, Detection, and Control Research Program, Duke University Medical Center, Durham, North Carolina 27710, USA
Obstet Gynecol 95:119-27. 2000..To investigate the clinical prognostic factors that influence ovarian cancer survival in women with early-onset epithelial ovarian cancer using population-based data...
Age at natural menopause and the risk of epithelial ovarian cancerJ M Schildkraut
Program for Prevention, Detection, and Control Research, Duke Comprehensive Cancer Center, Durham, North Carolina 27710, USA
Obstet Gynecol 98:85-90. 2001..To investigate the relationship between age at natural menopause and risk of developing epithelial ovarian cancer...
Polymorphisms in BRCA1 and BRCA2 and risk of epithelial ovarian cancerRobert M Wenham
Department of Obstetrics and Gynecology Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Clin Cancer Res 9:4396-403. 2003..We have examined whether BRCA2 N372H or common amino acid-changing polymorphisms in BRCA1 predispose to ovarian cancer...
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white womenRachel T Palmieri
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Cancer Epidemiol Biomarkers Prev 17:3567-72. 2008..This analysis shows the importance of consortia, like the OCAC, in either confirming or refuting the validity of putative findings in studies with smaller sample sizes. (Cancer Epidemiol Biomarkers Prev 2008;17(12):3567-72)...
No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North CarolinaJohnathan M Lancaster
Department of Obstetrics and Gynecology/Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina 27710, USA
Cancer Epidemiol Biomarkers Prev 12:226-7. 2003
Anthropometric measurements and epithelial ovarian cancer risk in African-American and White womenCathrine Hoyo
Department of Community and Family Medicine, Duke University Medical Center, 2424 Erwin Rd, Hock Plaza, Ste 602, Durham, NC 27710, USA
Cancer Causes Control 16:955-63. 2005..0; 95% CI = 0.7-1.4). These findings support the hypothesis that obesity is an important risk factor of ovarian cancer among African-Americans and Whites and also suggest that height may be a risk factor specific to African-Americans...
Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumorM F Vine
Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
Gynecol Oncol 83:466-71. 2001..The objective was to describe and compare types and duration of symptoms among women with invasive versus borderline ovarian tumors...
Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer riskMonique A Spillman
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University, DUMC Box 3079, Durham, NC 27710, USA
Gynecol Oncol 97:543-9. 2005..It has been suggested that the 6A allele of the type I TGFbeta receptor (TGFbetaR1) polyalanine repeat tract polymorphism may increase susceptibility to various types of cancer including ovarian cancer...
Early onset baldness and prostate cancer riskW Denmark-Wahnefried
Division of Urology Duke University Medical Center, Durham, North Carolina 27710, USA
Cancer Epidemiol Biomarkers Prev 9:325-8. 2000....
Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortiumAndrew Berchuck
Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA
Adv Exp Med Biol 622:53-67. 2008
Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controlsDora Il'yasova
Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27710, USA
Cancer Epidemiol Biomarkers Prev 18:1232-8. 2009..These controls seem to present a reasonable choice for clinic-centered case-control studies...
A prospective study of weight gain after premenopausal hysterectomyPatricia G Moorman
Department of Community and Family Medicine, Box 2949, Duke University Medical Center, 2424 Ervin Road, Suite 602, Durham, NC 27705, USA
J Womens Health (Larchmt) 18:699-708. 2009..The purpose of this analysis was to assess weight gain in premenopausal women in the first year after hysterectomy compared with a control group of women with intact uteri and ovaries...
Ovarian cancer risk factors in African-American and white womenPatricia G Moorman
Duke University Medical Center, 2424 Erwin Road, Suite 602, Durham, NC 27705, USA
Am J Epidemiol 170:598-606. 2009..There is a clear need for further research on etiologic factors for ovarian cancer in African-American women...
Predictors of variation in serum IGF1 and IGFBP3 levels in healthy African American and white menCathrine Hoyo
Department of Community and Family Medicine, Duke University Medical Center, Box 2914, Durham, NC 27710, USA
J Natl Med Assoc 101:711-6. 2009..Factors associated with variation in circulating levels of these peptide hormones remain unclear...
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomasCathrine Hoyo
Department of Community and Family Medicine, Duke University, Durham, NC 27710, USA
Int J Cancer 125:2673-8. 2009..5002G > A genotype and EGA was not evident. These findings suggest that nonsynonymous polymorphisms in M6P/IGF2R may contribute to the risks of EGA and noncardia adenocarcinomas. Larger studies are required to confirm these findings...
Pre-counseling education materials for BRCA testing: does tailoring make a difference?Celette Sugg Skinner
Duke University Medical Center, Department of Community and Family Medicine and the Duke Comprehensive Cancer Center, Durham, NC 27710, USA
Genet Test 6:93-105. 2002..91% NPM; p < 0.05). TPMs showed an advantage in increasing knowledge and enhancing accuracy of perceived risk. Both are critical components of informed decision making...
Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysisPatricia G Moorman
Cancer Prevention Detection and Control Research Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27705, USA
Breast Cancer Res Treat 124:441-51. 2010..However, our results should be interpreted cautiously given the overall inconsistency in the epidemiologic literature on modifiers of BRCA1 and BRCA2...
Menopausal hormones and risk of ovarian cancerPatricia G Moorman
Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27710, USA
Am J Obstet Gynecol 193:76-82. 2005..The objective of this study was to determine if use of menopausal hormones was associated with ovarian cancer and if risk varied by type of hormone used...
Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal womenPatricia G Moorman
Department of Community and Family Medicine, Cancer Prevention, Detection and Control Research Program, Duke University Medical Center, Durham, NC 27705, USA
Am J Epidemiol 167:1059-69. 2008..Findings suggest that associations between ovarian cancer and reproductive characteristics vary by menopausal status. Additional research is needed to further elucidate risk factors for postmenopausal disease...
Racial differences in enrolment in a cancer genetics registryPatricia G Moorman
Cancer Prevention Detection and Control Research Program, Duke University Medical Center, 239 Hanes House, Trent Drive, Box 2949, Durham, NC 27710, USA
Cancer Epidemiol Biomarkers Prev 13:1349-54. 2004..Most studies have little information about nonparticipants, making it difficult to identify characteristics associated with enrolment and how they might vary by race...
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancersAndrew Berchuck
Division of Gynecologic Oncology, Duke University Medical Center, Box 3079, Durham, NC 27710, USA
Cancer Epidemiol Biomarkers Prev 13:2141-7. 2004..In this study, we sought to determine whether this polymorphism affects ovarian cancer risk...
Antidepressant medication use [corrected] and risk of ovarian cancerPatricia G Moorman
Cancer Prevention, Detection, and Control Research Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27710, USA
Obstet Gynecol 105:725-30. 2005..The objective of this paper was to evaluate whether women with ovarian cancer were more likely to report past use of antidepressants than control women...
Grade-specific prostate cancer associations of IGF1 (CA)19 repeats and IGFBP3-202A/C in blacks and whitesCathrine Hoyo
Department of Community and Family Medicine, Hanes House Room 347, Trent Drive, Box 2914, Medical Center, Duke University Medical Center, Durham, NC 27710, USA
J Natl Med Assoc 99:718-22. 2007..If confirmed in larger studies, these findings support the hypothesis that the association between IGFBP3 C allele and prostate cancer is grade specific in both ethnic groups...
Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopyCelette Sugg Skinner
Duke University Medical Center, Durham, NC 27710, USA
J Gen Intern Med 20:360-5. 2005..Most (79%) reported CRIS had "caused" their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings...
Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States)Patricia G Moorman
Cancer Prevention, Detection, and Control Research Program, Department of Community and Family Medicine, Duike Universiti Medical Center, Durham, NC 27710, USA
Cancer Causes Control 13:807-11. 2002..To compare two methods for calculating lifetime ovulatory cycles (LOC) to determine if more detailed menstrual cycle information results in stronger associations with ovarian cancer...
Recreational physical activity and ovarian cancer risk and survivalPatricia G Moorman
Cancer Prevention, Detection and Control Research Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, NC 27705, USA
Ann Epidemiol 21:178-87. 2011..We examined associations between self-reported physical activity and ovarian cancer risk and survival in a population-based, case-control study in North Carolina...
Factors associated with African Americans' enrollment in a national cancer genetics registryC S Skinner
Duke Comprehensive Cancer Center, Durham, NC, USA
Community Genet 11:224-33. 2008..Education was also bivariately associated with enrollment, but mediation analysis indicated that the operational mechanism of education's influence on enrollment was through trust...
Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controlsMarilyn F Vine
Cancer Prevention, Detection and Control Research Program, Box 2949, Duke University Medical Center, Durham, NC 27710, USA
Gynecol Oncol 90:75-82. 2003..CONCLUSION: Earlier diagnosis of ovarian cancer may be possible if women and physicians recognize the importance of combinations of seemingly unrelated symptoms, especially those identified as occurring longer before diagnosis...
Estrogen bioactivation, genetic polymorphisms, and ovarian cancerThomas A Sellers
Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33602, USA
Cancer Epidemiol Biomarkers Prev 14:2536-43. 2005..015). Although preliminary, this study provides some support for the hypothesis that low-penetrance susceptibility alleles may influence risk of epithelial ovarian cancer...
Characterization of BRCA1 and BRCA2 mutations in a large United States sampleSining Chen
Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
J Clin Oncol 24:863-71. 2006..Existing studies have focused on Ashkenazi Jews (AJ) or on families from outside the United States. In this article, we consider the US population using the largest US-based cohort to date of both AJ and non-AJ families...
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani
The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21205 2011, USA
Ann Intern Med 147:441-50. 2007..At least 7 models for estimating the probabilities of having a mutation are used widely in clinical and scientific activities; however, the merits and limitations of these models are not fully understood...
Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancerThomas A Sellers
Division of Cancer Prevention and Control, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA
Cancer Epidemiol Biomarkers Prev 17:397-404. 2008..10 frequency; odds ratio, 0.07; P = 0.01) compared with the most common haplotype (0.39 frequency). These results suggest that genetic polymorphisms in the glycoslyation process may be novel risk factors for ovarian cancer...
Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosisFrancesmary Modugno
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15261, USA
Am J Obstet Gynecol 191:733-40. 2004..We investigated whether the odds ratios for ovarian cancer that were associated with oral contraceptive use, childbearing, hysterectomy, and tubal ligation differ among women with and without endometriosis...
Consortium analysis of 7 candidate SNPs for ovarian cancerSusan J Ramus
Translational Research Laboratory, University College London EGA Institute for Women s Health, London, United Kingdom
Int J Cancer 123:380-8. 2008..These null results for SNPs identified from relatively large initial studies shows the importance of replicating associations by a consortium approach...
Genetic variation in the one-carbon transfer pathway and ovarian cancer riskLinda E Kelemen
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer Res 68:2498-506. 2008..Interventions with modifiable factors such as multivitamin intake may reduce risk...
Exogenous hormone use and meningioma risk: what do we tell our patients?Elizabeth B Claus
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut, USA
Cancer 110:471-6. 2007....
Epidemiology of intracranial meningiomaElizabeth B Claus
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut 06520 8034, USA
Neurosurgery 57:1088-95; discussion 1088-95. 2005..This review highlights current knowledge of meningioma epidemiology and new directions for research efforts in this field...
Research Grants
- MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCERJoellen Schildkraut; Fiscal Year: 2007..Elucidation of the role of reproductive and environmental risk factors and genetic susceptibility could facilitate identification of high-risk women who would be ideal candidates for preventive interventions. ..
- The Molecular Epidemiology Of Ovarian CancerJoellen M Schildkraut; Fiscal Year: 2010..Ness), Los Angeles (Drs. Pearce and Wu) and Seattle (Dr. Rossing). Further confirmation will be pursued in collaboration with the Ovarian Cancer Association Consortium (OCAC) in the future. ..
- Meningioma: Risk Factors and Quality of LifeJoellen Schildkraut; Fiscal Year: 2009..This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma. ..
- Meningioma: Risk Factors and Quality of LifeJoellen M Schildkraut; Fiscal Year: 2010..This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma. ..
- Epidemiology of Ovarian Cancer in African-American WomenJoellen M Schildkraut; Fiscal Year: 2010..This study will provide new insight into both the etiology and prognosis of ovarian cancer in African-American women. ..
- MOLECULAR EPIDEMIOLOGY OF OVARIAN CANCERJoellen Schildkraut; Fiscal Year: 2002..Published preliminary studies have already shown an association with abnormal expression of p53 in ovarian tumors and epidemiologic markers of ovulation. ..
- CAROLINA AND GEORGIA GENETICS NETWORK CENTERJoellen Schildkraut; Fiscal Year: 2004..Within this application, we propose to take advantage of our expertise and resources to ascertain registrants by augmenting referral services and by piloting the selective use of our unique registries. ..
- Meningioma: Risk Factors and Quality of LifeJoellen Schildkraut; Fiscal Year: 2009..This study represents the first concentrated effort to examine environmental and genetic risk factors for meningioma. ..
